IP Library Assignment 066377/0563
Patent Assignment
Reel/Frame 066377/0563

Confirmatory License

Recorded: 2024-01-29 Pages: 2
Assignor
DANA-FARBER CANCER INST
Executed: 2023-10-24
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property (1)
Method of Assessing the Efficacy of a Test Agent for Modulating Programmed Death 1 (Pd-1) Signaling by Using Anti-Phosphotyrosinylated Pd-1 Monoclonal Antibodies
Application: 17/934,441 →
Publication: US 2023/0331847
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 14, 2023
From: FREEMAN, GORDON J.; BU, XIA
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 062689/0822 →
Assignment of Assignor's Interest Feb 14, 2023
From: BOUSSIOTIS, VASSILIKI A.; PATSOUKIS, NIKOLAOS; WEAVER, JESSICA; STRAUSS, LAURA
To: BETH ISRAEL DEACONESS MEDICAL CENTER
Reel/Frame 062689/0839 →
Assignment of Assignor's Interest Feb 14, 2023
From: JUNEJA, VIKRAM R.; SHARPE, ARLENE H.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 062689/0847 →